1 |
Kucher AN, Valiakhmetov NR, Salakhov RR, Golubenko MV, Pavlyukova EN, Nazarenko MS. Phenotype variation of hypertrophic cardiomyopathy in carriers of the p.Arg870His pathogenic variant in the MYH7 gene. Bûll sib med 2022;21:205-216. [DOI: 10.20538/1682-0363-2022-3-205-216] [Reference Citation Analysis]
|
2 |
Tsuda E, Ito Y, Kato Y, Sakaguchi H, Ohuchi H, Kurosaki K. Thirty-year outcome in children with hypertrophic cardiomyopathy based on the type. J Cardiol 2022:S0914-5087(22)00194-0. [PMID: 35961804 DOI: 10.1016/j.jjcc.2022.07.016] [Reference Citation Analysis]
|
3 |
Lander BS, Zhao Y, Hasegawa K, Maurer MS, Tower-rader A, Fifer MA, Reilly MP, Shimada YJ. Comprehensive Proteomics Profiling Identifies Patients With Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in the Hypertrophic Cardiomyopathy Population. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.839409] [Reference Citation Analysis]
|
4 |
Zhang N, Cheng S, Niu H, Gu M, Peng H, Sun Z, Liu X, Deng Y, Chen X, Hua W. Association of QTc Interval and V4-S Wave With Appropriate ICD Therapy in Hypertrophic Cardiomyopathy. Front Cardiovasc Med 2022;9:882662. [DOI: 10.3389/fcvm.2022.882662] [Reference Citation Analysis]
|
5 |
Nguyen MB, Mital S, Mertens L, Jeewa A, Friedberg MK, Aguet J, Adler A, Lam CZ, Dragulescu A, Rakowski H, Villemain O. Pediatric Hypertrophic Cardiomyopathy: Exploring the Genotype-Phenotype Association. J Am Heart Assoc 2022;:e024220. [PMID: 35179047 DOI: 10.1161/JAHA.121.024220] [Reference Citation Analysis]
|
6 |
Östman-Smith I, Sjöberg G, Alenius Dahlqvist J, Larsson P, Fernlund E. Sudden cardiac death in childhood hypertrophic cardiomyopathy is best predicted by a combination of electrocardiogram risk-score and HCMRisk-Kids score. Acta Paediatr 2021;110:3105-15. [PMID: 34314540 DOI: 10.1111/apa.16045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|